Mark For: OMLEYA® trademark registration is intended to cover the categories of pharmaceutical preparations for the treatment of endothelial diseases and disorders, renal diseases, transplant complications, ischemia-reperfusion injury and hematological, autoimmune, neurological, immunological and inflammation-related disease and disorders; biologics for the treatment of endothelial diseases and disorders, renal diseases, transplant complications, ischemia-reperfusion injury and hematological, autoimmune, neurological, immunological and inflammation-related disease and disorders. [all]
Status
2020-04-22 UTC
LIVE APPLICATION Published for Opposition
A pending trademark application has been examined by the Office and has been published in a way that provides an opportunity for the public to oppose its registration.
(Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed Use
No
Current Use
No
Intent To Use
Yes
Filed ITU
Yes
44D Filed
No
44E Current
No
66A Current
No
Current Basis
No
No Basis
No
Attorney Name
Anne H. Peck
Law Office Assigned
M50
Employee Name
CORDOVA, RAUL
Timeline
2019-05-30
Application Filed
2019-08-28
Location: TMO LAW OFFICE 114 - EXAMINING ATTORNEY ASSIGNED
2019-08-28
Status: Live/Pending
2019-08-28
Transaction Date
2020-03-04
Location: PUBLICATION AND ISSUE SECTION
2020-04-07
Published
2020-04-07
Status: Application has been published for opposition. The opposition period begins on the date of publication.
ANNE H. PECK COOLEY LLP 1299 PENNSYLVANIA AVENUE NW SUITE 700 WASHINGTON, DC 20004
Good, Services, and Codes
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical preparations for the treatment of endothelial diseases and disorders, renal diseases, transplant complications, ischemia-reperfusion injury and hematological, autoimmune, neurological, immunological and inflammation-related disease and disorders; biologics for the treatment of endothelial diseases and disorders, renal diseases, transplant complications, ischemia-reperfusion injury and hematological, autoimmune, neurological, immunological and inflammation-related disease and disorders
International Codes:
5
U.S. Codes:
006,018,044,046,051,052
Type Code
Type
GS0051
Pharmaceuticals and pharmaceutical preparations; biologics
Trademark Filing History
Description
Date
Proceeding Number
PUBLISHED FOR OPPOSITION
2020-04-07
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2020-04-07
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2020-03-18
APPROVED FOR PUB - PRINCIPAL REGISTER
2020-02-28
TEAS/EMAIL CORRESPONDENCE ENTERED
2020-02-26
88889
TEAS RESPONSE TO OFFICE ACTION RECEIVED
2020-02-25
CORRESPONDENCE RECEIVED IN LAW OFFICE
2020-02-25
88889
PRIORITY ACTION WRITTEN
2019-08-28
67424
PRIORITY ACTION E-MAILED
2019-08-28
6326
NOTIFICATION OF PRIORITY ACTION E-MAILED
2019-08-28
6326
ASSIGNED TO EXAMINER
2019-08-20
67424
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.